Moody's Corporation (MCO) Stock Price & Analysis
Moody's Corporation (MCO) is trading at USD 480.51, down 2.15% today, as of October 23, 2026 at 15:45 UTC (US market open; quotes may be delayed), according to Nexqual market data.
MCO last closed at USD 491.05; today's session has ranged USD 478–491.73 on volume of 270,439 shares. Market capitalization is $82.85B, with a 52-week range of USD 402.28–546.88 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 15:46 UTC.
Also available as compact Markdown for AI agents: nexqual.com/MCO.md
Key facts (MCO)
- Last four reported quarters (through Sep 30, 2026): revenue $8.18B, net income $2.88B (35.3% margin), free cash flow $2.98B (SEC filings).
- Valuation: P/E 28.7x (avg 41.4x at the last 3 fiscal year-ends), EV/EBITDA 21.3x, net debt $5.29B.
- 17 of 80 tracked superinvestors hold MCO (13F, Q2 2026 (1 investor on Q3 2026, filed early)): 1 new, 0 added, 6 reduced, 10 unchanged.
- Analysts: Buy (mean 2.04 on a 1–5 scale) (24 analysts), mean target USD 552.14 (range 480–600).
- Total return with dividends: 1Y +1.1% vs S&P 500 +14.7%; 5Y +24.1% vs S&P 500 +77.4%.
- Next earnings: 2026-10-21, EPS estimate USD 3.58, revenue estimate $1.93B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (MCO)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $6.22B | $5.47B | $5.92B | $7.09B | $7.72B | $8.18B |
| Gross profit | $4.58B | $3.85B | $4.23B | $5.14B | $5.75B | — |
| Operating income | $2.84B | $1.88B | $2.14B | $2.88B | $3.35B | $3.64B |
| Net income | $2.21B | $1.37B | $1.61B | $2.06B | $2.46B | $2.88B |
| EPS (diluted) | $11.78 | $7.44 | $8.73 | $11.26 | $13.67 | — |
| Free cash flow | $1.87B | $1.19B | $1.88B | $2.52B | $2.58B | $2.98B |
| Gross margin | 73.7% | 70.5% | 71.5% | 72.6% | 74.4% | — |
| Operating margin | 45.7% | 34.4% | 36.1% | 40.6% | 43.4% | 44.6% |
| Net margin | 35.6% | 25.1% | 27.2% | 29.0% | 31.9% | 35.3% |
| Revenue growth | +15.8% | -12.1% | +8.2% | +19.8% | +8.9% | — |
| Cash + short-term investments | $1.90B | $1.86B | $2.19B | $2.97B | $2.45B | — |
| Total debt | $7.41B | $7.39B | $7.00B | $7.43B | $6.99B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Sep 30, 2026) (MCO)
P/E 28.7x · P/S 10.1x · EV/EBITDA 21.3x · EV/Sales 10.8x · P/FCF 27.8x · P/B 25.4x · FCF yield 3.59% · Earnings yield 3.48% · Dividend yield (paid, TTM) 0.86% · Buyback yield (TTM) 3.61% · Net debt $5.29B · EV $88.1B
P/E at fiscal year-ends: Dec 2025 37.4x, Dec 2024 42.0x, Dec 2023 44.7x.
Superinvestors (SEC 13F-HR, Q2 2026) (MCO)
17 of 80 tracked investors hold MCO (1 investor on Q3 2026, filed early). Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change | Quarter |
|---|---|---|---|---|---|
| Valley Forge Capital | Valley Forge Capital Management | 19.14% | $597M | Unchanged | Q2 2026 |
| Chris Hohn | TCI Fund Management | 12.30% | $6.49B | Unchanged | Q2 2026 |
| Chuck Akre | Akre Capital Management | 10.26% | $524M | Reduced -7.2% | Q2 2026 |
| Guy Spier | Aquamarine Capital | 8.49% | $12.2M | Unchanged | Q2 2026 |
| John Armitage | Egerton Capital | 7.57% | $744M | Reduced -3.9% | Q3 2026 |
| Bryan Lawrence | Oakcliff Capital | 5.74% | $15.4M | New position | Q2 2026 |
| AKO Capital | 4.52% | $194M | Reduced -16.2% | Q2 2026 | |
| Warren Buffett | Berkshire Hathaway | 3.73% | $11.2B | Unchanged | Q2 2026 |
| AltaRock Partners | 3.23% | $137M | Reduced -64.9% | Q2 2026 | |
| William Von Mueffling | Cantillon Capital Management | 1.23% | $8.2M | Reduced -95.4% | Q2 2026 |
| Thomas Gayner | Markel Group | 0.74% | $96.9M | Unchanged | Q2 2026 |
| Van Den Berg Management I | 0.55% | $2.6M | Reduced -2.4% | Q2 2026 | |
| Francis Chou | Chou Associates | 0.31% | $679K | Unchanged | Q2 2026 |
| Yacktman Asset Management | 0.07% | $5.6M | Unchanged | Q2 2026 | |
| Dodge & Cox Funds | Dodge & Cox | <0.01% | $549K | Unchanged | Q2 2026 |
| Glenn Greenberg | Brave Warrior Advisors | <0.01% | $213K | Unchanged | Q2 2026 |
| Bill Nygren | Oakmark Funds | <0.01% | $863K | Unchanged | Q2 2026 |
Analysts (MCO)
Consensus Buy (mean 2.04 on a 1–5 scale), 24 analysts; mean target USD 552.14 (low 480, high 600).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-22 | Morgan Stanley | Target raised | Equal-Weight | $470 → $480 |
| 2026-10-22 | B of A Securities | Target lowered | Buy | $580 → $575 |
| 2026-10-22 | BMO Capital | Target raised | Market Perform | $490 → $511 |
| 2026-10-22 | Wells Fargo | Target lowered | Overweight | $597 → $595 |
| 2026-10-22 | Stifel | Target lowered | Buy | $550 → $537 |
| 2026-10-16 | RBC Capital | Target lowered | Outperform | $610 → $575 |
| 2026-10-14 | JP Morgan | Target lowered | Overweight | $570 → $555 |
| 2026-10-13 | BMO Capital | Target lowered | Market Perform | $515 → $490 |
| 2026-10-07 | Morgan Stanley | Target lowered | Equal-Weight | $512 → $470 |
| 2026-07-27 | Mizuho | Target raised | Neutral | $521 → $530 |
| 2026-07-23 | Baird | Target raised | Outperform | $557 → $572 |
| 2026-07-23 | Wells Fargo | Target raised | Overweight | $590 → $597 |
Total return (dividends reinvested) (MCO)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | +1.1% | +24.1% |
| S&P 500 (SPY) | +14.7% | +77.4% |
| Per year | +1.1% | +4.4% |
| Volatility (annualized) | 28.3% | 27.9% |
| Max drawdown | -23.6% (Jan 2026→Feb 2026) | -41.3% (Oct 2021→Oct 2022) |
MCO revenue by business segment (quarter ended Sep 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| MIS | $1.09B | 53.7% | -1.0% |
| MA | $936.0M | 46.3% | +3.0% |
| Total revenue | $2.02B | 100% | — |
MCO revenue by product line (quarter ended Sep 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Recurring Revenue | $928.0M | 45.9% | +6.1% |
| Transaction Revenue | $8.0M | 0.4% | -76.5% |
| Total revenue | $2.02B | 100% | — |
MCO revenue by region (quarter ended Sep 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| United States | $1.13B | 56.1% | +1.4% |
| Non-U.S. | $889.0M | 43.9% | +0.0% |
| — EMEA (part of Non-U.S.) | $596.0M | 29.5% | +0.3% |
| — Asia-Pacific (part of Non-U.S.) | $178.0M | 8.8% | -1.1% |
| — Americas (part of Non-U.S.) | $115.0M | 5.7% | +0.0% |
| Total revenue | $2.02B | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
MCO company outlook (results filed Oct 21, 2026)
- “Guidance as of October 21, 2026.”
Quoted word-for-word from the SEC 8-K results press release.
MCO analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Dec 2026) | $3.58 | $3.69 | -2.9% | $1.93B | 21 |
| Next quarter (ends Mar 2027) | $4.72 | $4.77 | -1.1% | $2.20B | 18 |
| Current fiscal year (ends Dec 2026) | $16.80 | $16.89 | -0.5% | $8.23B | 24 |
| Next fiscal year (ends Dec 2027) | $18.68 | $18.83 | -0.8% | $8.78B | 24 |
MCO options: expected move
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 28 | 27.5% | ±6.2% |
| Dec 18, 2026 | 56 | 26.3% | ±8.3% |
| Jan 15, 2027 | 84 | 26.1% | ±10.1% |
| Feb 19, 2027 | 119 | 27.4% | ±12.6% |
| May 21, 2027 | 210 | 27.8% | ±16.8% |
30-day implied volatility 27.7% vs 23.8% realized over the last 30 trading days. Put/call ratio (volume) 6.17. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 15:46 UTC)
| Price | USD 480.51 |
|---|---|
| Change | ▼ 2.15% (down) |
| Previous Close | USD 491.05 |
| Open | USD 486 |
| Day Range | USD 478 – 491.73 |
| 52-Week Range | USD 402.28 – 546.88 |
| Volume | 270,439 shares |
| Market Cap | $82.85B |
| Exchange | NYQ |
Technical Analysis (MCO)
Nexqual's technical model rates MCO "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of October 23, 2026 at 15:46 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 54.54 (neutral) |
| vs SMA50 | Above (USD 477.77) |
| MACD | 3.44 (positive) |
Analyst Ratings (MCO)
Wall Street analysts rate MCO "Buy" based on 24 analysts, with a mean price target of USD 552.14 (range USD 480–600), per Nexqual as of October 23, 2026 at 15:46 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 24 |
| Mean Target | USD 552.14 |
| High Target | USD 600 |
| Low Target | USD 480 |
| Buy / Hold / Sell | 18 / 6 / 0 |
Earnings (MCO)
| Next Earnings Date | 2026-10-21 |
|---|---|
| EPS Estimate | USD 3.58 |
| Revenue Estimate | $1.93B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-09-30 | USD 4.14 vs est 4.25 ▼ miss |
| 2026-06-30 | USD 4.68 vs est 4.25 ▲ beat |
| 2026-03-31 | USD 4.33 vs est 4.22 ▲ beat |
| 2025-12-31 | USD 3.64 vs est 3.44 ▲ beat |
Source: Nexqual, October 23, 2026 at 15:46 UTC.
Financials & Fundamentals (MCO)
| Total Revenue | $8.18B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +0.80% |
| Gross Margin | +74.63% |
| Operating Margin | +46.27% |
| Profit Margin | +35.26% |
| ROE | +76.74% |
| Debt / Equity | 2.2 |
| Current Ratio | 1.29 |
| Total Cash | $1.62B |
| Total Debt | $7.49B |
| Free Cash Flow (last four quarters to Sep 2026, SEC 10-Q / 10-K) | $2.98B (36.4% of revenue) |
Source: Nexqual, October 23, 2026 at 15:46 UTC.
Financial Health Score (MCO)
Nexqual rates Moody's Corporation's overall financial health "Solid" across five dimensions, as of October 23, 2026 at 15:46 UTC.
| Growth | Solid — Revenue +9% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 75%, operating 46% (last 12 months) |
| Balance Sheet | Weak — $1.62B cash and investments vs $6.91B debt (Sep 2026, SEC) |
| Cash Flow | Strong — FCF $2.98B (last 4 quarters to Sep 2026, SEC), 36% margin |
| Efficiency | Strong — ROE 77%, ROA 15.6% |
Ownership (MCO)
| Insider Ownership | +14.45% |
|---|---|
| Institutional Ownership | +79.05% |
| Shares Outstanding | 172.42M |
| Float | 158.17M |
| Short % of Float | +1.90% |
Source: Nexqual, October 23, 2026 at 15:46 UTC.
Leadership (MCO)
Moody's Corporation is led by Robert Scott Fauber, President, CEO & Director, per Nexqual as of October 23, 2026 at 15:46 UTC.
| President, CEO & Director | Robert Scott Fauber |
|---|---|
| Senior VP & CFO | Noemie Clemence Heuland |
| President of Moody's Investors Service Inc. & CEO of Moody's Ratings | Michael L. West |
| Senior Vice President of Corporate Communications | Michael Adler |
Major Backers & Investors (MCO)
Notable institutional backers of Moody's Corporation include Berkshire Hathaway, TCI Fund Management Ltd, FMR, LLC, according to Nexqual as of October 23, 2026 at 15:46 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Berkshire Hathaway | 14.31% |
| TCI Fund Management Ltd | 8.31% |
| FMR, LLC | 2.89% |
| Fidelity | 2.43% |
| NORGES BANK | 1.38% |
| Morgan Stanley | 1.38% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 7.83% |
| BlackRock | 7.23% |
| State Street | 4.12% |
| Geode Capital | 2.32% |
Source: Nexqual, October 23, 2026 at 15:46 UTC.
From Moody's Corporation's Latest SEC 10-K Filing (filed 2026-02-18)
Key Strengths & Strategy (as disclosed to the SEC)
- MA is comprised of: i) a premier fixed income and economic research business (Research & Insights); ii) a data business powered by the world's largest database on companies and credit (Data & Information); and iii) three cloud-based subscription businesses serving banking, insurance and KYC workflows (Decision Solutions), enabling customers to integrate Moody's proprietary data and analytics through a number of delivery channels.
- We believe our trusted and curated proprietary data, as well as our domain expertise, are crucial in an environment that is increasingly using Gen AI and agentic AI.
- Our integrated approach provides stakeholders with a more comprehensive view of risk, helping them to make better decisions and unlock opportunities.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ICE | Intercontinental Exchange Inc. | USD 162.9 | ▼ 0.58% |
| CME | CME Group Inc. | USD 306.23 | ▲ 0.08% |
| NDAQ | Nasdaq, Inc. | USD 103.23 | ▼ 0.07% |
| SPGI | S&P Global Inc. | USD 450.1 | ▼ 0.66% |
| MSCI | MSCI Inc. | USD 613.11 | ▼ 1.15% |
| COIN | Coinbase Global, Inc. | USD 165.6 | ▼ 2.07% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 15:46 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt